"Chemotherapy Principles"(PDF). American Cancer Society. Arquivado dende o orixinal(PDF) o 13 de decembro de 2016. Consultado o 20 August 2014.
doi.org
dx.doi.org
Riss TL, Moravec RA; Moravec (February 2004). "Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays". Assay Drug Dev Technol2 (1): 51–62. PMID15090210. doi:10.1089/154065804322966315.
Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL (July 2007). "A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers". Anal. Biochem.366 (2): 197–206. PMID17512890. doi:10.1016/j.ab.2007.04.007.
Fan F, Wood KV; Wood (February 2007). "Bioluminescent assays for high-throughput screening". Assay Drug Dev Technol5 (1): 127–36. PMID17355205. doi:10.1089/adt.2006.053.
Dearden, J. C. (2003). "In silico prediction of drug toxicity". Journal of computer-aided molecular design17 (2–4): 119–27. PMID13677480. doi:10.1023/A:1025361621494.
nih.gov
ncbi.nlm.nih.gov
Riss TL, Moravec RA; Moravec (February 2004). "Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays". Assay Drug Dev Technol2 (1): 51–62. PMID15090210. doi:10.1089/154065804322966315.
Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL (July 2007). "A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers". Anal. Biochem.366 (2): 197–206. PMID17512890. doi:10.1016/j.ab.2007.04.007.
Fan F, Wood KV; Wood (February 2007). "Bioluminescent assays for high-throughput screening". Assay Drug Dev Technol5 (1): 127–36. PMID17355205. doi:10.1089/adt.2006.053.
Dearden, J. C. (2003). "In silico prediction of drug toxicity". Journal of computer-aided molecular design17 (2–4): 119–27. PMID13677480. doi:10.1023/A:1025361621494.